Cargando…

Pharmacological treatment options for mast cell activation disease

Mast cell activation disease (MCAD) is a term referring to a heterogeneous group of disorders characterized by aberrant release of variable subsets of mast cell (MC) mediators together with accumulation of either morphologically altered and immunohistochemically identifiable mutated MCs due to MC pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molderings, Gerhard J., Haenisch, Britta, Brettner, Stefan, Homann, Jürgen, Menzen, Markus, Dumoulin, Franz Ludwig, Panse, Jens, Butterfield, Joseph, Afrin, Lawrence B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/ https://www.ncbi.nlm.nih.gov/pubmed/27132234 http://dx.doi.org/10.1007/s00210-016-1247-1

Ejemplares similares

Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options
por: Molderings, Gerhard J, et al.
Publicado: (2011)

Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA
por: Molderings, Gerhard J., et al.
Publicado: (2017)

Familial Occurrence of Systemic Mast Cell Activation Disease
por: Molderings, Gerhard J., et al.
Publicado: (2013)

Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease
por: Vysniauskaite, Milda, et al.
Publicado: (2015)

A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023)

Case Report: Treatment of systemic mastocytosis with sunitinib
por: Molderings, Gerhard J., et al.
Publicado: (2017)

White matter abnormalities are also repeatedly present in patients with systemic mast cell activation syndrome
por: Haenisch, B, et al.
Publicado: (2018)

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020)

Mast cell activation symptoms are prevalent in Long-COVID
por: Weinstock, Leonard B., et al.
Publicado: (2021)

Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis
por: Seidel, Holger, et al.
Publicado: (2021)

Prostaglandin D(2)-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study
por: Schäfer, Dirk, et al.
Publicado: (2014)

Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness
por: Molderings, G. J., et al.
Publicado: (2020)

Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2022)

Correction : Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome
por: Schmidt, Tobias Jürgen, et al.
Publicado: (2023)

Utility of hydroxyurea in mast cell activation syndrome
por: Afrin, Lawrence B
Publicado: (2013)

Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series
por: Weinstock, Leonard B., et al.
Publicado: (2022)

Mast Cell-Mediated Mechanisms of Nociception
por: Aich, Anupam, et al.
Publicado: (2015)

Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
por: Afrin, Lawrence B.
Publicado: (2014)

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
por: Afrin, Lawrence B., et al.
Publicado: (2022)

Chemical Intolerance and Mast Cell Activation: A Suspicious Synchronicity
por: Palmer, Raymond F., et al.
Publicado: (2023)

Mast cell deposition and activation may be a new explanation for epiploic appendagitis
por: Weinstock, Leonard B., et al.
Publicado: (2018)

The 1,4-benzodiazepine Ro5-4864 (4-chlorodiazepam) suppresses multiple pro-inflammatory mast cell effector functions
por: Yousefi, Omid Sascha, et al.
Publicado: (2013)

CYTOLOGICAL AND PHARMACOLOGICAL OBSERVATIONS ON THE RELEASE OF HISTAMINE BY MAST CELLS
por: Fawcett, Don W.
Publicado: (1954)

Endoscopic resection techniques for colorectal neoplasia: Current developments
por: Dumoulin, Franz Ludwig, et al.
Publicado: (2019)

Non-pharmacological Treatment Options in the Management of Diabetes Mellitus
por: Raveendran, Arkiath V, et al.
Publicado: (2018)

Minimizing Oxidation of Freeze-Dried Monoclonal Antibodies in Polymeric Vials Using a Smart Packaging Approach
por: Härdter, Nicole, et al.
Publicado: (2021)

Prediction of Unwanted Crystallization of Freeze-Dried Protein Formulations Using α-Relaxation Measurements
por: Groël, Sebastian, et al.
Publicado: (2023)

The Pharmacological Options in the Treatment of Eating Disorders
por: Milano, W., et al.
Publicado: (2013)

Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022)

Extracorporeal Membrane Oxygenation in Nivolumab Associated Pneumonitis
por: Schneider, Thomas-Michael, et al.
Publicado: (2017)

“Awake” ECCO(2)R superseded intubation in a near-fatal asthma attack
por: Schneider, Thomas-Michael, et al.
Publicado: (2017)

Reply to Schurr and Gottwald
por: Dumoulin, Franz Ludwig, et al.
Publicado: (2018)

Migraine pathogenesis and state of pharmacological treatment options
por: Sprenger, Till, et al.
Publicado: (2009)

Current pharmacologic options for patients with Alzheimer's disease
por: Reichman, William E
Publicado: (2003)

Pharmacological adjuncts to stop bleeding: options and effectiveness
por: Panteli, M., et al.
Publicado: (2015)

Pharmacologic Treatment Options for Insomnia in Patients with Schizophrenia
por: Stummer, Lauren, et al.
Publicado: (2018)

Current and Emerging Pharmacological Treatment Options for Dementia
por: Ringman, John M., et al.
Publicado: (2006)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

COVID-19 and Possible Pharmacological Preventive Options
por: Duner, Pontus, et al.
Publicado: (2020)

Calorimetric Investigation of the Relaxation Phenomena in Amorphous Lyophilized Solids
por: Groёl, Sebastian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oeert034039m6cn7svvhs29idg